RE:RE:Nov 11 - release its third quarter 2021 financial resultsSnowballgrowth wrote: MrMugsy wrote: MONTREAL, Nov. 04, 2021 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) (“Knight”), a leading pan-American (ex-USA) specialty pharmaceutical company, will release its third quarter 2021 financial results on Thursday, November 11, 2021 prior to market opening. Following the release, Knight will hold a conference call and audio webcast. Knight cordially invites all interested parties to participate in this call.
Date: Thursday, November 11, 2021
Time: 8:30 a.m. ET
Telephone: Toll Free: 866-269-4264 or International 1-647-792-1240
Webcast: www.gud-knight.com or Webcast
This is a listen-only audio webcast. Media Player is required to listen to the broadcast.
Some sales growth and better margins could be great. Expectations are very low at current stock price.
Yes - heading into the best potential for efficency gain with the different business units at GUD. Also ... could be at a low point for currencies going forward - watching closely (future).
but - most importantly - will be when investors/investment houses decide GUD needs to be added as a core holding. That's really what we're waiting for if you're interested in share price appreciation (IMO).
That's the "show me" part of the business - convincing investment houses that GUD is on that operational growth curve and should be a core holding. That rush into GUD is the point that demand begins to outpace supply. No way I'd bet on a date for that - though.
at some point !